Find a Doctor

George Fountzilas

Aristotle University Of Thessaloniki
Male

Bio


George Fountzilas is in Thessaloniki, Greece. They have been an author on 372 peer reviewed articles and participated in 3 clinical trials in the past 15 years.

Contact

Thessaloniki, ESYE12, GR

Latest Research


Latest Advance
Study
  • Condition: Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer (MBC)
  • Journal: British journal of cancer
  • Treatment Used: Cabaziitaxel
  • Number of Patients: 84
  • Published —
This study evaluated the effectiveness and safety of cabazitaxel as second-line treatment (treatment after the initial treatment has failed, stopped working, or has side effects that aren't tolerated) for patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) previously treated with taxanes.
Latest Advance
Study
  • Condition: Colon cancer
  • Journal: Annals of oncology : official journal of the European Society for Medical Oncology
  • Treatment Used: Bevacizumab
  • Number of Patients: 2867
  • Published —
The study researched the effects of Bevacizumab in addition to their treatment for colon cancer.
Latest Advance
Study
  • Condition: Locally Advanced or Metastatic Pancreatic Cancer
  • Journal: Targeted oncology
  • Treatment Used: Gemcitabine Combined with the mTOR Inhibitor Temsirolimus
  • Number of Patients: 30
  • Published —
The study aimed to determine the effects of various doses of Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in treating locally advanced or metastatic pancreatic cancer.
Latest Advance
Study
  • Condition: Renal-cell carcinoma
  • Journal: International journal of clinical oncology
  • Treatment Used: Bevacizumab/temsirolimus
  • Number of Patients: 39
  • Published —
This study evaluated the combination of bevacizumab with temsirolimus in patients with advanced renal-cell carcinoma relapsing after first-line treatment.
Latest Advance
Study
  • Condition: Metastatic Colorectal Cancer (mCRC)
  • Journal: Clinical colorectal cancer
  • Treatment Used: Leucovorin, 5-Fluorouracil, Irinotecan, and Oxaliplatin (FOLFIRI) plus Aflibercept
  • Number of Patients: 73
  • Published —
This trial studied the effectiveness and safety of leucovorin, 5-fluorouracil, irinotecan, and oxaliplatin (FOLFIRI) combined with aflibercept as first-line treatment for patients with metastatic colorectal cancer (mCRC).

All Publications
View All


Publication
Study
  • Journal: Data in brief
  • Published —
Genotyping data of routinely processed matched primary/metastatic tumor samples.
Publication
Study
  • Journal: Human pathology
  • Published —
Genotype-phenotype associations in colorectal adenocarcinomas and their matched metastases.

Contact

Thessaloniki, ESYE12, GR

Insurance

Contact them to find out if they accept your insurance plan.